Early Phase I data shows promise for mRNA cancer immunotherapy in advanced solid cancers

Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers.

Cell therapy biotech Affini-T Therapeutics appears to cut staff

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 28, 2025

Masimo picks Katie Szyman as CEO

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Name: Katie Szyman New title: CEO, Masimo

January 22, 2025

Quantiphi Invests in Transcell to Advance AI-Driven Drug Discovery

What You Should Know: – Quantiphi, an AI-first digital engineering company, announced a strategic minority investment in Transcell, a pioneering stem cell-based biotech innovator. This

August 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.